WAM
ANIK icon

Wealthspire Advisors (Maryland)’s Anika Therapeutics ANIK Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-8
Closed – – 537
2019
Q1 		$0 Hold
8
– – ﹤0.01% 2468
2018
Q4 		$0 Sell
8
-40
-83% -$1.44K ﹤0.01% 2422
2018
Q3 		$2K Sell
48
-3
-6% -$119 ﹤0.01% 2123
2018
Q2 		$2K Buy
51
+17
+50% +$700 ﹤0.01% 2116
2018
Q1 		$2K Sell
34
-88
-72% -$4.97K ﹤0.01% 2127
2017
Q4 		$7K Buy
122
+28
+30% +$1.55K ﹤0.01% 1714
2017
Q3 		$5K Buy
94
+2
+2% +$105 ﹤0.01% 1780
2017
Q2 		$5K Buy
+92
New +$4.24K ﹤0.01% 1747

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s ANIK Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Anika Therapeutics (ANIK) in Q2 2019, closing a stake of 8 shares.

Wealthspire Advisors (Maryland) first reported a position in ANIK in Q2 2017 and held it in 8 quarters. The position peaked at $7K in Q4 2017. 165 funds tracked by Wall St. Rank hold ANIK as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Anika Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 8 Anika Therapeutics shares in Q2 2019.
  • Wealthspire Advisors (Maryland) first reported a position in Anika Therapeutics in Q2 2017 and held it in 8 quarters.
  • Wealthspire Advisors (Maryland)'s Anika Therapeutics position peaked at $7K in Q4 2017.
  • 165 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.